Document is current
Any future updates will be listed below
-
Authors
Choi, Woo Jin
Sapisochin, Gonzalo
O’Kane, Grainne M.
- License Information
-
More Information
Article History
Received: 24 January 2023
Accepted: 25 January 2023
First Online: 8 February 2023
Disclosures
: Grainne O’Kane discloses - Honoraria: Eisai, Roche, AstraZeneca, Consulting or Advisory Role: Eisai, Roche, AstraZeneca Canada, Incyte, Travel, Accommodations, Expenses: AstraZeneca/MedImmune. Gonzalo Sapisochin discloses consultancy for Astra-Zeneca, Roche, Novartis, Evidera, and Integra. Gonzalo Sapisochin has received financial compensation for talks for Roche, Astrazeneca, Chiesi, and Integra. Gonzalo Sapisochin has received a grant from Roche. None of the other authors have any conflicts of interest to declare.
